{"id":163559,"date":"2022-06-07T04:41:06","date_gmt":"2022-06-07T04:41:06","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=163559"},"modified":"2022-06-07T04:41:06","modified_gmt":"2022-06-07T04:41:06","slug":"cryofibrinogenemia","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/","title":{"rendered":"Cryofibrinogenemia"},"content":{"rendered":"<p>The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-163559","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cryofibrinogenemia - Definition of Cryofibrinogenemia<\/title>\n<meta name=\"description\" content=\"The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cryofibrinogenemia - Definition of Cryofibrinogenemia\" \/>\n<meta property=\"og:description\" content=\"The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T04:41:06+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/\",\"name\":\"Cryofibrinogenemia - Definition of Cryofibrinogenemia\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-06-07T04:41:06+00:00\",\"dateModified\":\"2022-06-07T04:41:06+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cryofibrinogenemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cryofibrinogenemia - Definition of Cryofibrinogenemia","description":"The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/","og_locale":"en_US","og_type":"article","og_title":"Cryofibrinogenemia - Definition of Cryofibrinogenemia","og_description":"The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/","og_site_name":"Glossary","article_published_time":"2022-06-07T04:41:06+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/","name":"Cryofibrinogenemia - Definition of Cryofibrinogenemia","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-06-07T04:41:06+00:00","dateModified":"2022-06-07T04:41:06+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The coagulation of blood in small vessels, caused by cryofibrinogens in the plasma. This rare symptomatic illness can cause ulceration, gangrene, necrosis, or purpura, especially when the skin is exposed to cold. Cryofibrinogenemia usually develops secondarily, e.g., in patients with metastatic cancer, lymphoma, or collagenvascular disease.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/cryofibrinogenemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Cryofibrinogenemia"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/163559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=163559"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/163559\/revisions"}],"predecessor-version":[{"id":163560,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/163559\/revisions\/163560"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=163559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=163559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=163559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}